We have signed an exclusive license agreement with Orthofix Medical Inc. to commercialize overseas our range of innovative products dedicated to stimulation.
“As a company with a long history of treating patients in Europe, we are excited to enter into this agreement that will expand the availability of our bone and joint cartilage systems to patients in the U.S.. Aligning with Orthofix’s expertise and distribution capacity in the stimulation market enables us to provide even more physicians access to our innovative products to improve patient outcomes.”